Identification of threshold prostate specific antigen levels to optimize the detection of clinically significant prostate cancer by magnetic resonance imaging/ultrasound fusion guided biopsy.

scientific article

Identification of threshold prostate specific antigen levels to optimize the detection of clinically significant prostate cancer by magnetic resonance imaging/ultrasound fusion guided biopsy. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.JURO.2014.08.002
P932PMC publication ID4684948
P698PubMed publication ID25117476
P5875ResearchGate publication ID264745419

P50authorMohummad Minhaj SiddiquiQ37831177
Soroush Rais-BahramiQ40114897
Bradford J. WoodQ40114938
Nabeel A ShakirQ50652518
Baris TurkbeyQ88769455
Peter L ChoykeQ90059714
Peter A PintoQ90059716
Arvin K GeorgeQ96240193
Lambros StamatakisQ97527341
Maria J MerinoQ107749611
Jason T. RothwaxQ114421919
Chinonyerem OkoroQ114421920
Dima RaskolnikovQ114421921
Annerleim Walton-DiazQ114421922
P2093author name stringRichard Simon
Daniel Su
P2860cites workCurrent status of magnetic resonance imaging (MRI) and ultrasonography fusion software platforms for guidance of prostate biopsiesQ27001055
Standards of Reporting for MRI-targeted Biopsy Studies (START) of the Prostate: Recommendations from an International Working GroupQ30054617
Target detection: magnetic resonance imaging-ultrasound fusion-guided prostate biopsyQ33605381
NCCN clinical practice guidelines in oncology: prostate cancer early detectionQ34616553
D'Amico risk stratification correlates with degree of suspicion of prostate cancer on multiparametric magnetic resonance imagingQ35202301
Magnetic resonance imaging/ultrasound fusion guided prostate biopsy improves cancer detection following transrectal ultrasound biopsy and correlates with multiparametric magnetic resonance imagingQ35354750
Prostate cancer: can multiparametric MR imaging help identify patients who are candidates for active surveillance?Q36946494
Real-time MRI-TRUS fusion for guidance of targeted prostate biopsiesQ37149144
Gleason score and lethal prostate cancer: does 3 + 4 = 4 + 3?Q37280719
Value of targeted prostate biopsy using magnetic resonance-ultrasound fusion in men with prior negative biopsy and elevated prostate-specific antigenQ37381526
Defining the optimal prostate-specific antigen threshold for the diagnosis of prostate cancerQ37439227
Pathological outcomes in men with low risk and very low risk prostate cancer: implications on the practice of active surveillanceQ37689254
Multiparametric 3T prostate magnetic resonance imaging to detect cancer: histopathological correlation using prostatectomy specimens processed in customized magnetic resonance imaging based molds.Q37937948
Diagnostic value of biparametric magnetic resonance imaging (MRI) as an adjunct to prostate-specific antigen (PSA)-based detection of prostate cancer in men without prior biopsies.Q38180533
Accuracy of multiparametric magnetic resonance imaging in confirming eligibility for active surveillance for men with prostate cancerQ39391979
Gleason score 7 prostate cancer on needle biopsy: is the prognostic difference in Gleason scores 4 + 3 and 3 + 4 independent of the number of involved cores?Q39601468
Assessing prostate cancer risk: results from the Prostate Cancer Prevention TrialQ39752227
Utility of multiparametric magnetic resonance imaging suspicion levels for detecting prostate cancerQ40114843
Multiparametric magnetic resonance imaging (MRI) and subsequent MRI/ultrasonography fusion-guided biopsy increase the detection of anteriorly located prostate cancersQ40183239
Magnetic resonance imaging/ultrasound-fusion biopsy significantly upgrades prostate cancer versus systematic 12-core transrectal ultrasound biopsy.Q45967722
Pathological outcomes of candidates for active surveillance of prostate cancerQ46511086
Improving detection of clinically significant prostate cancer: magnetic resonance imaging/transrectal ultrasound fusion guided prostate biopsy.Q53304507
Comparing the Gleason prostate biopsy and Gleason prostatectomy grading system: the Lahey Clinic Medical Center experience and an international meta-analysisQ81036362
Negative predictive value for cancer in patients with "gray-zone" PSA level and prior negative biopsy: preliminary results with multiparametric 3.0 Tesla MRQ84253472
P4510describes a project that usesmagnetic resonance imagingQ161238
P433issue6
P407language of work or nameEnglishQ1860
P921main subjectprostate cancerQ181257
biopsyQ179991
P304page(s)1642-1648
P577publication date2014-08-09
P1433published inJournal of UrologyQ15709979
P1476titleIdentification of threshold prostate specific antigen levels to optimize the detection of clinically significant prostate cancer by magnetic resonance imaging/ultrasound fusion guided biopsy
P478volume192

Reverse relations

cites work (P2860)
Q423219871.5-Tesla Multiparametric-Magnetic Resonance Imaging for the detection of clinically significant prostate cancer
Q38823661A urologist's perspective on prostate cancer imaging: past, present, and future
Q57317620Author Reply
Q26774839Current role of multiparametric magnetic resonance imaging for prostate cancer
Q41690642Does focal incidental 18F-FDG PET/CT uptake in the prostate have significance?
Q53111203Efficiency of Prostate Cancer Diagnosis by MR/Ultrasound Fusion-Guided Biopsy vs Standard Extended-Sextant Biopsy for MR-Visible Lesions.
Q53887860Improved biopsy efficiency with MR/ultrasound fusion-guided prostate biopsy.
Q35820198Is magnetic resonance/ultrasound fusion prostate biopsy better than systematic prostate biopsy? An updated meta- and trial sequential analysis
Q52624219MRI in early prostate cancer detection: how to manage indeterminate or equivocal PI-RADS 3 lesions?
Q38545811MRI-guided biopsies and minimally invasive therapy for prostate cancer
Q39129035Magnetic Resonance Imaging Provides Added Value to the Prostate Cancer Prevention Trial Risk Calculator for Patients With Estimated Risk of High-grade Prostate Cancer Less Than or Equal to 10.
Q37055000Magnetic Resonance Imaging-Ultrasound Fusion-Guided Prostate Biopsy: Review of Technology, Techniques, and Outcomes
Q36123058Magnetic Resonance Imaging/Transrectal Ultrasonography Fusion Prostate Biopsy Significantly Outperforms Systematic 12-Core Biopsy for Prediction of Total Magnetic Resonance Imaging Tumor Volume in Active Surveillance Patients
Q40899372Magnetic resonance imaging detected prostate evasive anterior tumours: Further insights
Q38377827Missing the Mark: Prostate Cancer Upgrading by Systematic Biopsy over Magnetic Resonance Imaging/Transrectal Ultrasound Fusion Biopsy
Q39174624Multicentre evaluation of targeted and systematic biopsies using magnetic resonance and ultrasound image-fusion guided transperineal prostate biopsy in patients with a previous negative biopsy
Q34177428Multiparametric MRI in the PSA screening era
Q28081873Multiparametric-MRI in diagnosis of prostate cancer
Q38524498Optimizing Patient Population for MP-MRI and Fusion Biopsy for Prostate Cancer Detection
Q38753426PI-RADSv2: How we do it.
Q38843182Risk stratification of prostate cancer: integrating multiparametric MRI, nomograms and biomarkers
Q52741581Role of multi-parametric MRI of the prostate for screening and staging: Experience with over 1500 cases.
Q57107304The Role of Imaging in Prostate Cancer Care Pathway: Novel Approaches to Urologic Management Challenges Along 10 Imaging Touch Points
Q53634864The Role of Magnetic Resonance Image Guided Prostate Biopsy in Stratifying Men for Risk of Extracapsular Extension at Radical Prostatectomy.
Q30988469The detection of significant prostate cancer is correlated with the Prostate Imaging Reporting and Data System (PI-RADS) in MRI/transrectal ultrasound fusion biopsy
Q91705711The effect of multiplicity of PI-RADS 3 lesions on cancer detection rate of confirmatory targeted biopsy in patients diagnosed with prostate cancer and managed with active surveillance
Q38504909The role of MRI in active surveillance for prostate cancer
Q38746242The significance of anterior prostate lesions on multiparametric magnetic resonance imaging in African-American men.
Q53589252Use of serial multiparametric magnetic resonance imaging in the management of patients with prostate cancer on active surveillance.

Search more.